548 Results for "

PM

" in MedChemExpress (MCE) Product Catalog:
Products (548)

548 Results for "PM" in MCE Product Catalog:

179
179 Publications Verification
Cat. No.: HY-10181A
CAS No.: 854001-07-3
Purity:  98.86%
Synonyms: BMS-354825 hydrochloride
Research Areas:  

Cancer

Dasatinib (BMS-354825) hydrochloride is a highly potent, ATP competitive, orally active dual Src/Bcr-Abl inhibitor with potent antitumor activity. The Kis are 16 pM and 30 pM for Src and Bcr-Abl, respectively. Dasatinib hydrochloride inhibits Bcr-Abl and Src with IC50s of <1.0 nM and 0.5 nM, respectively . Dasatinib hydrochloride also induces apoptosis and autophagy.
loading...
    loading...
179
179 Publications Verification
Cat. No.: HY-10181B
CAS No.: 863127-77-9
Purity:  99.58%
Synonyms: BMS-354825 monohydrate
Research Areas:  

Cancer

Dasatinib (BMS-354825) monohydrate is a highly potent, ATP competitive, orally active dual Src/Bcr-Abl inhibitor with potent antitumor activity. The Kis are 16 pM and 30 pM for Src and Bcr-Abl, respectively. Dasatinib monohydrate inhibits Bcr-Abl and Src with IC50s of <1.0 nM and 0.5 nM, respectively . Dasatinib monohydrate also induces apoptosis and autophagy.
loading...
    loading...
179
179 Publications Verification
Cat. No.: HY-10181
CAS No.: 302962-49-8
Purity:  99.83%
Synonyms: BMS-354825
Dasatinib (BMS-354825) is a highly potent, ATP competitive, orally active dual Src/Bcr-Abl inhibitor with potent antitumor activity. The Kis are 16 pM and 30 pM for Src and Bcr-Abl, respectively. Dasatinib inhibits Bcr-Abl and Src with IC50s of <1.0 nM and 0.5 nM, respectively. Dasatinib also induces apoptosis and autophagy, and can cross the blood-brain barrier .
loading...
    loading...
70
70 Cited Publications
Cat. No.: HY-15392
CAS No.: 1273579-40-0
Purity:  99.42%
Target:  

ROCK

Research Areas:  

Cardiovascular Disease

Chroman 1 is a highly potent and selective ROCK inhibitor. Chroman 1 is more potent against ROCK2 (IC50=1 pM) than ROCK1 (IC50=52 pM). Chroman 1 also has inhibitory activity against MRCK, with an IC50 of 150 nM .
loading...
    loading...
70
70 Cited Publications
Cat. No.: HY-15392A
Purity:  99.11%
Target:  

ROCK

Research Areas:  

Cardiovascular Disease

Chroman 1 dihydrochloride is a highly potent and selective ROCK inhibitor. Chroman 1 dihydrochloride is more potent against ROCK2 (IC50=1 pM) than ROCK1 (IC50=52 pM). Chroman 1 dihydrochloride also has inhibitory activity against MRCK, with an IC50 of 150 nM .
loading...
    loading...
58
58 Cited Publications
Cat. No.: HY-134813
CAS No.: 2621928-55-8
Purity:  99.97%
Target:  

Ras

Research Areas:  

Cancer

MRTX1133 is a noncovalent, potent, and selective alkyne-based KRAS G12D inhibitor. MRTX1133 optimally fills the switch II pocket and extends three substituents to favorably interact with the protein, resulting in an estimated KD against KRAS G12D of 0.2 pM. MRTX1133 prevents SOS1-catalyzed nucleotide exchange and/or formation of the KRAS G12D/GTP/RAF1 complex, thereby inhibiting mutant KRAS-dependent signal transduction. MRTX1133 selectively inhibits KRAS G12D mutant, but not KRAS wild-type, tumor cells. MRTX1133 has single digit nanomolar activity in cellular assays and marked in vivo efficacy in tumor models harboring KRAS G12D mutations .
loading...
    loading...
56
56 Cited Publications
Cat. No.: HY-19741
CAS No.: 1430844-80-6
Target:  

Bcl-2 Family

Research Areas:  

Cancer

A-1331852 is an orally available BCL-XL selective inhibitor with a Ki of less than 10 pM.
loading...
    loading...
48
48 Cited Publications
Cat. No.: HY-10465
CAS No.: 1009119-65-6
Purity:  99.68%
Synonyms: BMS-790052 dihydrochloride; EBP 883 dihydrochloride
Target:  

HCV

Research Areas:  

Infection

Daclatasvir dihydrochloride (BMS-790052 dihydrochloride) is a potent and orally active HCV NS5A protein inhibitor with EC50s range of 9-146 pM for multiple HCV replicon genotypes. Daclatasvir dihydrochloride is also an organic anion transporting polypeptide 1B (OATP1B) and OATP1B3 inhibitor with IC50s of 1.5 μM and 3.27 μM, respectively .
loading...
    loading...
48
48 Cited Publications
Cat. No.: HY-10466
CAS No.: 1009119-64-5
Purity:  98.68%
Synonyms: BMS-790052; EBP 883
Target:  

HCV

Research Areas:  

Infection

Daclatasvir (BMS-790052) is a potent and orally active HCV NS5A protein inhibitor with EC50s range of 9-146 pM for multiple HCV replicon genotypes. Daclatasvir is also a organic anion transporting polypeptide 1B (OATP1B) and OATP1B3 inhibitor with IC50s of 1.5 µM and 3.27 µM, respectively .
loading...
    loading...
47
47 Cited Publications
Cat. No.: HY-P1001
CAS No.: 169332-60-9
Target:  

Caspase

Research Areas:  

Cancer

Ac-DEVD-CHO is a Caspase-3 inhibitor with a Ki value of 230 pM.
loading...
    loading...
45
45 Cited Publications
Cat. No.: HY-10095
CAS No.: 204697-65-4
Purity:  99.83%
Synonyms: BIBN-4096; BIBN 4096BS
Target:  

CGRP Receptor

Research Areas:  

Neurological Disease

Olcegepant (BIBN-4096) is a potent and selective non-peptide antagonist of the calcitonin gene-related peptide 1 (CGRP1) receptor with IC50 of 0.03 nM and Ki of 14.4 pM for human CGRP .
loading...
    loading...
45
45 Cited Publications
Cat. No.: HY-10095A
CAS No.: 586368-06-1
Purity:  99.11%
Synonyms: BIBN-4096 hydrochloride; BIBN4096BS hydrochloride
Target:  

CGRP Receptor

Research Areas:  

Neurological Disease

Olcegepant hydrochloride (BIBN-4096 hydrochloride) is a potent and selective non-peptide antagonist of the calcitonin gene-related peptide 1 (CGRP1) receptor with IC50 of 0.03 nM and with a Ki of 14.4 pM for human CGRP .
loading...
    loading...
43
43 Cited Publications
Cat. No.: HY-15656
CAS No.: 1032900-25-6
Purity:  99.98%
Synonyms: LDK378
Ceritinib (LDK378) is a selective, orally bioavailable, and ATP-competitive ALK tyrosine kinase inhibitor with an IC50 of 200 pM. Ceritinib also inhibits IGF-1R, InsR, and STK22D with IC50 values of 8, 7, and 23 nM, respectively. Ceritinib shows great antitumor potency .
loading...
    loading...
43
43 Cited Publications
Cat. No.: HY-15656A
CAS No.: 1380575-43-8
Purity:  99.90%
Synonyms: LDK378 dihydrochloride
Ceritinib (LDK378) dihydrochloride is a selective, orally bioavailable and ATP-competitive ALK tyrosine kinase inhibitor with an IC50 of 200 pM. Ceritinib dihydrochloride also inhibits IGF-1R, InsR, and STK22D with IC50 values of 8, 7, and 23 nM, respectively. Ceritinib dihydrochloride shows great antitumor potency .
loading...
    loading...
37
37 Cited Publications
Cat. No.: HY-15659
CAS No.: 1243243-89-1
Purity:  99.88%
Synonyms: C59
Wnt-C59 (C59) is a highly potent and oral porcupine (PORCN) inhibitor with an IC50 of 74 pM.
loading...
    loading...
33
33 Cited Publications
Cat. No.: HY-15593
CAS No.: 1380288-87-8
Purity:  99.93%
Synonyms: EPZ-5676
Research Areas:  

Cancer

Pinometostat (EPZ-5676) is a potent DOT1L histone methyltransferase inhibitor with a Ki of 80 pM.
loading...
    loading...
32
32 Cited Publications
Cat. No.: HY-12451
CAS No.: 172922-91-7
Purity:  98.57%
Synonyms: 6-Formylindolo[3,2-b]carbazole
Research Areas:  

Others

FICZ is a potent aryl hydrocarbon receptor (AhR) agonist with a Kd of 70 pM.
loading...
    loading...
32
32 Cited Publications
Cat. No.: HY-P0017
CAS No.: 9087-70-1
Aprotinin is a bovine pancreatic trypsin inhibitor (BPTI) inhibitor which inhibits trypsin and chymotrypsin with Kis of 0.06 pM and 9 nM, respectively.
loading...
    loading...
31
31 Cited Publications
Cat. No.: HY-15602
CAS No.: 1256388-51-8
Purity:  99.69%
Synonyms: GS-5885
Target:  

HCV SARS-CoV

Research Areas:  

Infection

Ledipasvir (GS-5885) is an inhibitor of the hepatitis C virus NS5A, with EC50s of 34 pM and 4 pM against genotype 1a and 1b replicon, respectively. Ledipasvir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 1.62 μM .
loading...
    loading...
31
31 Cited Publications
Cat. No.: HY-15602B
CAS No.: 1502654-87-6
Purity:  98.76%
Synonyms: GS-5885 D-tartrate
Target:  

HCV

Research Areas:  

Infection

Ledipasvir D-tartrate is an inhibitor of the hepatitis C virus NS5A, with EC50 values of 34 pM against GT1a and 4 pM against GT1b replicon.
loading...
    loading...